EEG-Guided Cognitive Function Preservation in Patients With Brain Tumors
A Prospective Single-Arm Study of EEG-Based Neural Signal Decoding for Cognitive Function Preservation in Patients Undergoing Brain Tumor Surgery
研究概览
详细说明
This is a prospective, single-center, single-arm interventional study designed to investigate an EEG-based neural signal decoding strategy for higher-order cognitive function preservation in patients undergoing brain tumor surgery.
Eligible patients with brain tumors scheduled for surgical treatment will be enrolled. Participants will receive standardized neuropsychological assessments before and after surgery. High-density EEG recordings will be acquired during different stages of the perioperative period, including task-based and resting-state paradigms when applicable. Neural signal decoding methods will be used to extract cognitive-related electrophysiological features and evaluate their association with postoperative cognitive outcomes.
The primary objective is to evaluate the feasibility of EEG-based neural signal decoding for objective cognitive assessment and functional preservation during brain tumor surgery. Secondary objectives include exploring the relationship between electrophysiological biomarkers and neuropsychological performance, evaluating perioperative cognitive changes, and providing preliminary evidence for individualized cognitive protection strategies in brain tumor patients.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Bo Wang
- 电话号码:022-59065262
- 邮箱:dr.bo.wang@tmu.edu.cn
学习地点
-
-
Tianjin Municipality
-
Tianjin、Tianjin Municipality、中国、300350
- Tianjin Huanhu Hospital
-
接触:
- Bo Wang
- 电话号码:022-59065262
- 邮箱:dr.bo.wang@tmu.edu.cn
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Age 18 years to 75 years.
- Patients diagnosed with brain glioma and scheduled for surgical treatment.
- Conscious and able to understand study procedures.
- Able to complete neuropsychological assessments.
- Willing to participate and provide written informed consent.
Exclusion Criteria:
- Severe dysfunction of major organs (heart, lung, liver, or kidney).
- Severe psychiatric disorders or cognitive impairment.
- Severe language impairment preventing completion of study procedures.
- Any other condition judged by the investigator to make participation inappropriate.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:EEG-Guided Cognitive Function Preservation
Participants undergoing brain tumor surgery will receive the EEG-based neural signal decoding strategy in addition to standard surgical management for individualized cognitive function preservation.
Cognitive outcomes will be evaluated using standardized neuropsychological assessments.
|
EEG-based neural signal decoding will be performed during the perioperative period to identify cognitive functional networks and assist individualized cognitive function preservation during brain tumor surgery.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Mini-Mental State Examination (MMSE) Total Score
大体时间:Baseline, postoperative 1 week, postoperative 1 month, and postoperative 3 months
|
Cognitive function assessed using the Mini-Mental State Examination (MMSE).
The total score ranges from 0 to 30, with higher scores indicate better cognitive function.
|
Baseline, postoperative 1 week, postoperative 1 month, and postoperative 3 months
|
|
Montreal Cognitive Assessment (MoCA) Total Score
大体时间:Baseline, postoperative 1 week, postoperative 1 month, and postoperative 3 months
|
Cognitive function assessed using the Montreal Cognitive Assessment (MoCA).
The total score ranges from 0 to 30, with higher scores indicate better cognitive function.
|
Baseline, postoperative 1 week, postoperative 1 month, and postoperative 3 months
|
合作者和调查者
赞助
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 2026-BRAIN-TUMOR-COG-01
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.